Long COVID Questionnaire Responses

Long COVID risk factors identified in large cohort study of 65,000+ U.S. adults

This retrospective cohort study analyzed data from 65,464 U.S. adults in the All of Us Research Program to examine long COVID risk factors.

Long COVID leads to significant workforce exit and work productivity loss, Dutch cohort study finds

This prospective cohort study (PRIME post-COVID) in the Netherlands assessed workforce exit and work productivity loss among adults with pos

Long Covid is a stable, maladaptive immunometabolic state, not just random leftover damage, and it has big implications for how we design biomarkers and treatments.

FDA Leverages Real-World Data and Partnerships to Accelerate COVID-19 Response

The FDA and its partners are working to capture real-world data to identify and evaluate innovative approaches for responding to COVID-19 as

Long COVID to cost US $8 billion over three years, driven mainly by workforce productivity losses

Long COVID continues to affect over 44 million Americans, with an estimated $8 billion in economic costs over three years. More than 90% of

Rollout of Covid vaccines extraordinary feat - inquiry report